Nissab Boudjellab
6Patents
5h-index
13Co-inventors
52Inventor score
Filing activity: Nov 5, 1999 → Dec 23, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7268113B2 | Long lasting growth hormone releasing factor derivatives | Human Necessities | 23 | Expired |
| US7112567B2 | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders | Chemistry; Metallurgy | 18 | Expired |
| US6440417B1 | Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatments | Human Necessities | 15 | Expired |
| US7090851B1 | Long lasting fusion peptide inhibitors of viral infection | Chemistry; Metallurgy | 12 | Expired |
| US7737251B2 | Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders | Chemistry; Metallurgy | 7 | Active |
| US7582301B1 | Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides | Chemistry; Metallurgy | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.